Page last updated: 2024-08-17

triamcinolone acetonide and Leukemia, Pre-B-Cell

triamcinolone acetonide has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, MT; Litwack, G; Robertson, NM; Wickstrom, E1

Other Studies

1 other study(ies) available for triamcinolone acetonide and Leukemia, Pre-B-Cell

ArticleYear
Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1.
    Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Caspase 3; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 1; Gene Silencing; Glucocorticoids; Humans; Hydroxyurea; Immediate-Early Proteins; Immunoblotting; Molecular Sequence Data; Phosphoprotein Phosphatases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Phosphatase 1; Protein Tyrosine Phosphatases; RNA, Messenger; RNA, Small Interfering; Transfection; Triamcinolone Acetonide

2005